- Q3 sales grew 10.5% year-over-year to $1.72 billion; diluted EPS reached $0.53 versus $0.50 prior.
- TAVR sales growth guidance for FY2026 raised to 9.0%-9.5% from 8%-9%.
- Q4 guidance projects sales between $1.67-$1.75B and adjusted EPS of $0.61-$0.69.
Why is $EW moving today? · SEC 8-K archive
$EW SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $EW: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $EW filing catalyst
Why did $EW trigger an AI stock catalyst alert?
$EW triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Edwards Lifesciences Reports Q3 Sales Growth of 10.5%, Raises Full-Year TAVR Guidance. Key points: - Q3 sales grew 10.5% year-over-year to $1.72 billion; diluted EPS reached $0.53 versus $0.50 prior. - TAVR sales growth guidance for FY2026 raised to 9.0%-9.5% from 8%-9%. - Q4 guidance projects sales between $1.67-$1.75B and adjusted EPS of $0.61-$0.69.
How did $EW stock react after the SEC filing?
After the SEC 8-K for $EW, observed market reaction: T0 price $99.37. Past moves do not guarantee future results.
Where can I get real-time $EW SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $EW via Telegram and the VIP Web Terminal from €10/month.